The Ninth Circuit evaluated the antitrust implications of multiproduct or “bundled” discounts in Cascade Health Solutions v. PeaceHealth, CV-02-06032 (Sept. 4, 2007). In doing so, the Ninth Circuit rejected the controversial Third Circuit rule of LePage’s Inc. v. 3M, 324 F.3d 141 (3d Cir. 2003), reasoning that LePage’s was inconsistent with the longstanding practice of protecting businesses that engage in legitimate price competition from unwarranted legal risk. Expressly “part[ing] ways with” its sister circuit, the Ninth Circuit held that bundled discounts violate Section 2 of the Sherman Act only when they are below an appropriate measure of the defendant’s costs. The PeaceHealth opinion authored by Judge Ronald M. Gould establishes a clear point of disagreement between the circuits as
Partager sur
|
|
The US Court of Appeals for the Ninth Circuit applies a cost-based test to attempted monopolization claim premised on multiproduct discounting (Cascade Health Solutions / PeaceHealth)
L'accès à cet article est réservé aux abonnés
Déjà abonné ? Identifiez-vous
L’accès à cet article est réservé aux abonnés.
Lire gratuitement un article
Vous pouvez lire cet article gratuitement en vous inscrivant.
